CareToLive Believes that the lower Court was in error when it chose to summarily dismiss our lawsuit against the FDA, Richard Pazdur and Howard Scher along with our motion for emergency injunctive relief. We will never stop fighting until this injustice is overturned.

Click here to
read the brief requesting oral argument filed today.

Popularity: 25%

A tribute to John Fish.

We are very saddened to tell you that CareToLive member John Fish passed away from prostate cancer on Tuesday, December 18, 2007, without ever having the benefit of receiving provenge, the immunotherapy which he so desperately wanted. He was so hopeful that he would be able to get it 7 months ago, when it came before the FDA Advisory Committee of experts who voted it unanimously safe and 13 to 4 substantial evidence of efficacy (2 of the naysayers who “leaked” letters may be called before a Congressional Hearing – read on). Instead the FDA delayed approval, claiming they needed more data. Over 10 years of trials showing survival benefits, were not enough for them, despite the fact that 30,000 American men with PC are out of options, and the treatment has almost no side effects or safety issues. The chicanery going on at the FDA knows no bounds.

We can never thank John enough for all his efforts to right the wrongs in the FDA delay of Provenge. John was one of the lead Plaintiffs in our unprecedented, ongoing, CareToLive lawsuit filed by our attorney Kerry Donahue against the FDA, unfortunately under appeal, but not in time to help John. It was dismissed under a Catch 22, whereby the Court refused to hear the case concerning the delay of Provenge due to the fact that is was not denied, only delayed, so far for 7 months and what could be forever. Tell John that it is still pending. A lot of good that does him. For all intents and purposes Provenge is dead, until the FDA Commissioner Andrew Von Eschenbach decides whether to approve, delay or not approve, depending on whatever baloney is being dished out over at the FDA that day. Continue Reading One Fish, Two Fish, We are all Blue Fish — John Fish We Will Miss You »

Popularity: 25%

It is over 7 months since the FDA denied the Provenge Biologics License Application for Prostate Cancer. Last week John Fish, suffering from late stage prostate cancer, was admitted to a hospice without ever having been given the opportunity to receive this immunotherapy to try to strengthen his body to fight for his life. John has however, joined with CareToLive and hopefully although it may be too late for him, he and his wife Marlilyn have courageously stood toe to toe with us, along with many of our other members with prostate cancer, to try to make this treatment available for the rest of the 30,000 men who will surely die this year without it.

Finally! Thanks to the efforts of CareToLive, a non profit, led by attorney Kerry Donahue, and Scott Riccio of ARightToLive, and the many, many members and supporters of CareToLive and Provenge, an immunotherapy voted overwhelmingly safe and effective by an FDA panel of experts to approve this treatment for prostate cancer, and then denied without adequate explanation by the FDA, three of our congressmen, Mike Michaud of Maine, Dan Burton of Indiana, and Tim Ryan of Ohio are asking for a congressional hearing into what happened. We must continue to be vigilant and to contact our representatives in the Congress to keep the pressure on, and to demand a congressional hearing.

CONGRESSIONAL LETTER ASKING FOR A HEARING  PDF (click here) Please fax this letter to your own congressional representatives and ask them to join this action. TIA

An Easy Way To Contact Your Elected Officials - (click here) EVERY VOICE COUNTS!

This is a grassroots movement. We need EVERYBODY’S help. See you at the hearings!

Please visit our website and read our blogs to learn about the 3 “leaked” letters and so much more, Continue Reading The FDA Said NO, CareToLive & ARightToLive say GO FISH! »

Popularity: 41%